ϳԹ

Reliable Reagents for Revolutionary Therapies

As cell therapy development accelerates, keeping pace with the latest innovations is vital for driving your progress in research and clinical translation. Come by booth #501 at ISCT from May 7 - 10 or booth #1514 at ASGCT from May 13 - 17 to explore how our standardized and scalable solutions can help advance your research to the clinic. We’ll also be hosting talks and presenting scientific posters at both meetings.

Explore the content below for more details on our exhibitions, as well as additional scientific resources, on-demand webinars, and innovative products to support hematopoietic stem and progenitor cell culture, immune cell activation and expansion, and pluripotent stem cell differentiation for cell therapy development.


Global Showcases and Posters

ISCT 2025

Global Showcases

Posters

Wednesday, May 7
7:00 – 8:30 p.m.

Development of Robust T Cell Manufacturing Protocols in Bioreactors Using cGMP-Compliant Ancillary Reagents

Poster Number: 996

Speaker: Nooshin Tabatabaei-Zavareh, PhD, MD | Associate Director, Immunology, Culture & Applications

Thursday, May 8
6:00 – 7:30 p.m.

Animal Component- and Extracellular Vesicle-Free Medium Facilitates Isolation and Characterization of Small Extracellular Vesicles from Human Bone Marrow Mesenchymal Stromal Cells

Poster Number: 326

Speaker: Ravenska Wagey, PhD | Associate Director, Mesenchymal and Endothelial Cell Biology, Research & Development

ASGCT 2025

Workshop

Posters

Tuesday, May 13
6:00 – 7:30 p.m.

Enhanced Ex Vivo Expansion of Hematopoietic Stem Cells by a Novel Compound Cocktail

Speaker: Javed Manesia, PhD | Scientist, Research & Development, Hematology

Tuesday, May 13
6:00 – 7:30 p.m.

Serum- and Feeder-Free Generation of Multipotent Hematopoietic Progenitors from Pluripotent Stem Cells in a 3D Culture System

Speaker: Tim Le Fevre, PhD | Senior Scientist, Research & Development, Immune Cell Culture

Thursday, May 15
5:40 – 7:00 p.m.

Optimized CRISPR-Cas9 Editing of Primary Human Immune and CD34+ Hematopoietic Stem and Progenitor Cells Using a Mechanoporation Platform

Speaker: Eric Ouellet, PhD | Senior Scientist, Research & Development, Immune Cell Culture


Illustration of different custom service stages for cell therapy available from ϳԹ

Learn How We Can Support Your Regulatory and Compliance Needs

Get expert support to use our products and other ancillary materials (raw materials) for cell therapy development under the right regulatory framework. Our Services for Cell Therapy team can help you navigate complex regulatory requirements to find the best solution.

Learn More >


Browse Scientific Posters

Find out what ϳԹ scientists have been working on.


Featured Products and Solutions for Cell Therapy Development

Explore new technologies that can help you efficiently complete your experiments and take your research further.


StemSpan™-AOF, GMP

Culture and expand human hematopoietic cells in animal origin-free conditions with this medium, manufactured under relevant cGMPs.

Related Webinar:
Removing Animal Components from Your HSC Workflow


MethoCult™ Optimum

Achieve optimal growth of hematopoietic progenitor cells in colony-forming unit (CFU) assays of human bone marrow, mobilized peripheral blood, peripheral blood, and cord blood samples.

Related Webinar:
New Tools for the Ex Vivo Expansion of Human Hematopoietic Stem and Progenitor Cells


շѱDz™

Automate and standardize your CFU assays. The new 21 CFR Part 11 Compliance Software Add-On supports workflows consistent with FDA Title 21 CFR Part 11 regulations on electronic records.

Related Webinar:
Implementing the Colony-Forming Unit (CFU) Assay As a Potency Assay for Hematopoietic Cell Therapy Products


Featured: TeSR™-AOF, GMP

Consistently culture viral-safe, high-quality PSCs for further use in cell therapy development with an animal-origin free medium.

Related Webinar:
Quality by Design: Reagents and Support for hPSC-Derived Cell and Gene Therapies


mTeSR™ Plus, GMP

Gain control over your feeding schedule and achieve superior culture morphology with this stabilized feeder-free medium for human ES and iPS cells.

Related Webinar:
How to Transition hPSCs into mTeSR™ Plus


New:TeSR™-AOF 3D

Rapidly scale up high-quality hPSCs without requiring adaptation from 2D culture with animal origin-free TeSR™-AOF 3D.

Related Webinar
Robust Workflows for the Expansion of PSCs in 3D Suspension Culture


Featured: ܲԴǰܱ™-ݹ

Expand human T cells in serum- and xeno-free culture conditions with medium manufactured under relevant GMP guidelines for high yield and viability.

Related Video:
How to Optimize Your T Cell Therapy Workflow—Without the Use of Serum or Feeder Cells


Vials of ImmunoCult™ Human CD3/CD28/CD2 and ImmunoCult Human Cd3/CD28 T Cell Activators

Featured: GMP ImmunoCult™ Human T Cell Activators

Gently activate T cells for further use in cell therapy development and manufacturing—without the use of magnetic beads, feeder cells, or antigens.

Related Video:
CAR T Cell Manufacturing Workflow: Isolation, Activation and Expansion


STEMdiff™ NK Cell Kit

Robustly differentiate hPSC-derived NK cells for developing adoptive immunotherapies as well as for researching the basic biology of these cells

Related Video:
ISSCR Innovation Showcase: Differentiating Immune Cells from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures


MesenCult™-ACF Plus Medium

Animal component-free medium for human mesenchymal stem cells.

Related Video:
MesenCult™ for Mesenchymal Stromal Cell Derivation, Culture & Differentiation


STEMdiff™ Endothelial Expansion Culture Kit

Serum- and xeno-free medium and attachment substrate for expansion of human pluripotent stem cell-derived endothelial cells.

Related Brochure:


STEMdiff™ Blood Vessel Organoid Kit

Media and supplements for differentiation of human pluripotent stem cells to blood vessel organoids.

Related Webinar:
Modeling the Structural and Functional Features of Blood Vasculature with Blood Vessel Organoids


STEMdiff™ Cardiomyocyte Expansion Kit

A serum-free media kit for the expansion of early-stage hPSC-derived cardiomyocytes.

Related Poster:


MyoCult™ Differentiation Kit (Human)

Medium for the differentiation of human skeletal muscle progenitor cells (myoblasts) into myotubes.

Related Webinar:
3D Modeling of Skeletal Muscle for In Vitro Functional Assaying


STEMdiff™ Ventricular Cardiomyocyte Differentiation Kit

A serum-free culture medium kit for differentiation of human PSCs to ventricular cardiomyocytes.

Related Video:
Scaling-Up hPSC-Derived Cardiomyocytes for Preclinical and Therapeutic Applications



Mobilized Leukopaks

Obtain high-quality, high-volume, single-donor CD34+ cells from fresh peripheral blood leukopaks, now available from donors mobilized with either granulocyte colony-stimulating factor (G-CSF), plerixafor, or a combination of both.

Related Webinar:
How to Process a Leukopak for Downstream Cell Isolation


Human CD34+ Cells

Start experiments confidently with ready-to-use, ethically sourced human CD34+ cells from cord blood, bone marrow, or mobilized peripheral blood.

Related Webinar:
Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance


Immune Cell Subsets, Frozen

Schedule delivery of pan-T cells, B cells, NK cells, and more at your convenience.

Related Video:
How To Thaw Frozen Human Primary Cells


Healthy Control Human iPSC Line, Female, SCTi003-A

Start your research confidently with a reliable source of healthy, high-quality induced pluripotent stem cells (iPSCs) from the SCTi003-A cell line, certified by hPSCreg® and compatible for use with TeSR™ and STEMdiff™ media.

Related Flyer:


Fresh or Frozen Leukopaks

Obtain large numbers of fresh or frozen mononuclear cells to streamline your cell-based assays with fresh or frozen leukopaks.

Related Flyer:

Streamline your workflow with ThawSTAR®, an automated water-free thawing system for consistent performance. Visit: www.stemcell.com/ThawSTAR

See Featured Products for Cell Therapy Development >



Four headshots of speakers of the T Cell Talks

Advancing T Cell Therapies: Insights from the Translational T Cell Talks

On June 11, 2024, ϳԹ hosted the half-day virtual event “Translational T Cell Talks: Scaling for the Future” in collaboration with Scientist.com. The presentations from distinguished scientists and industry leaders, provided insights into the latest developments in translational T cell research and CAR T cell innovations, and concluded with a discussion on improving collaboration between industry and academia.

Watch Now >


A thumbnail image of the wallchart: Rational Combination of Cancer Therapies with PD1 Axis Blockade

Rational Combination of Cancer Therapies with PD1 Axis Blockade

Looking for ways to combine new immunotherapeutic targets and modalities for your translational research? Request this free Nature Reviews Cancer and Nature Reviews Immunology Wallchart.

Download Now >


Which Immune Cell Are You?

Take this personality quiz to find out which immune cell you’re most like.

Play Now >

Catch Up on the Latest Research with the Stem Cell Podcast

Join Daylon and Arun from the Stem Cell Podcast as they discuss the latest science along with guests like Dr. Carl June, Dr. Chuck Murray, and Dr. Connie Eaves. View the latest episode in the video below, or listen to previous episodes .



Explore Scientific Resources and Services for Cell and Gene Therapy Research